Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Follicular Lymphoma Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Chemotherapy
1.2.3 Radiotherapy
1.2.4 Monoclonal Antibodies
1.2.5 Stem Cell Transplantation
1.3 Market by Application
1.3.1 Global Follicular Lymphoma Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Follicular Lymphoma Treatment Market Perspective (2019-2030)
2.2 Follicular Lymphoma Treatment Growth Trends by Region
2.2.1 Global Follicular Lymphoma Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Follicular Lymphoma Treatment Historic Market Size by Region (2019-2024)
2.2.3 Follicular Lymphoma Treatment Forecasted Market Size by Region (2025-2030)
2.3 Follicular Lymphoma Treatment Market Dynamics
2.3.1 Follicular Lymphoma Treatment Industry Trends
2.3.2 Follicular Lymphoma Treatment Market Drivers
2.3.3 Follicular Lymphoma Treatment Market Challenges
2.3.4 Follicular Lymphoma Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Follicular Lymphoma Treatment Players by Revenue
3.1.1 Global Top Follicular Lymphoma Treatment Players by Revenue (2019-2024)
3.1.2 Global Follicular Lymphoma Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Follicular Lymphoma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Follicular Lymphoma Treatment Revenue
3.4 Global Follicular Lymphoma Treatment Market Concentration Ratio
3.4.1 Global Follicular Lymphoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Follicular Lymphoma Treatment Revenue in 2023
3.5 Follicular Lymphoma Treatment Key Players Head office and Area Served
3.6 Key Players Follicular Lymphoma Treatment Product Solution and Service
3.7 Date of Enter into Follicular Lymphoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Follicular Lymphoma Treatment Breakdown Data by Type
4.1 Global Follicular Lymphoma Treatment Historic Market Size by Type (2019-2024)
4.2 Global Follicular Lymphoma Treatment Forecasted Market Size by Type (2025-2030)
5 Follicular Lymphoma Treatment Breakdown Data by Application
5.1 Global Follicular Lymphoma Treatment Historic Market Size by Application (2019-2024)
5.2 Global Follicular Lymphoma Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Follicular Lymphoma Treatment Market Size (2019-2030)
6.2 North America Follicular Lymphoma Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Follicular Lymphoma Treatment Market Size by Country (2019-2024)
6.4 North America Follicular Lymphoma Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Follicular Lymphoma Treatment Market Size (2019-2030)
7.2 Europe Follicular Lymphoma Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Follicular Lymphoma Treatment Market Size by Country (2019-2024)
7.4 Europe Follicular Lymphoma Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Follicular Lymphoma Treatment Market Size (2019-2030)
8.2 Asia-Pacific Follicular Lymphoma Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Follicular Lymphoma Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Follicular Lymphoma Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Follicular Lymphoma Treatment Market Size (2019-2030)
9.2 Latin America Follicular Lymphoma Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Follicular Lymphoma Treatment Market Size by Country (2019-2024)
9.4 Latin America Follicular Lymphoma Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Follicular Lymphoma Treatment Market Size (2019-2030)
10.2 Middle East & Africa Follicular Lymphoma Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Follicular Lymphoma Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Follicular Lymphoma Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim GmbH
11.1.1 Boehringer Ingelheim GmbH Company Detail
11.1.2 Boehringer Ingelheim GmbH Business Overview
11.1.3 Boehringer Ingelheim GmbH Follicular Lymphoma Treatment Introduction
11.1.4 Boehringer Ingelheim GmbH Revenue in Follicular Lymphoma Treatment Business (2019-2024)
11.1.5 Boehringer Ingelheim GmbH Recent Development
11.2 Bristol-Myers Squibb Company
11.2.1 Bristol-Myers Squibb Company Company Detail
11.2.2 Bristol-Myers Squibb Company Business Overview
11.2.3 Bristol-Myers Squibb Company Follicular Lymphoma Treatment Introduction
11.2.4 Bristol-Myers Squibb Company Revenue in Follicular Lymphoma Treatment Business (2019-2024)
11.2.5 Bristol-Myers Squibb Company Recent Development
11.3 Celgene Corporation
11.3.1 Celgene Corporation Company Detail
11.3.2 Celgene Corporation Business Overview
11.3.3 Celgene Corporation Follicular Lymphoma Treatment Introduction
11.3.4 Celgene Corporation Revenue in Follicular Lymphoma Treatment Business (2019-2024)
11.3.5 Celgene Corporation Recent Development
11.4 Celldex Therapeutics, Inc.
11.4.1 Celldex Therapeutics, Inc. Company Detail
11.4.2 Celldex Therapeutics, Inc. Business Overview
11.4.3 Celldex Therapeutics, Inc. Follicular Lymphoma Treatment Introduction
11.4.4 Celldex Therapeutics, Inc. Revenue in Follicular Lymphoma Treatment Business (2019-2024)
11.4.5 Celldex Therapeutics, Inc. Recent Development
11.5 Celltrion, Inc.
11.5.1 Celltrion, Inc. Company Detail
11.5.2 Celltrion, Inc. Business Overview
11.5.3 Celltrion, Inc. Follicular Lymphoma Treatment Introduction
11.5.4 Celltrion, Inc. Revenue in Follicular Lymphoma Treatment Business (2019-2024)
11.5.5 Celltrion, Inc. Recent Development
11.6 Cellular Biomedicine Group, Inc.
11.6.1 Cellular Biomedicine Group, Inc. Company Detail
11.6.2 Cellular Biomedicine Group, Inc. Business Overview
11.6.3 Cellular Biomedicine Group, Inc. Follicular Lymphoma Treatment Introduction
11.6.4 Cellular Biomedicine Group, Inc. Revenue in Follicular Lymphoma Treatment Business (2019-2024)
11.6.5 Cellular Biomedicine Group, Inc. Recent Development
11.7 Coherus BioSciences, Inc.
11.7.1 Coherus BioSciences, Inc. Company Detail
11.7.2 Coherus BioSciences, Inc. Business Overview
11.7.3 Coherus BioSciences, Inc. Follicular Lymphoma Treatment Introduction
11.7.4 Coherus BioSciences, Inc. Revenue in Follicular Lymphoma Treatment Business (2019-2024)
11.7.5 Coherus BioSciences, Inc. Recent Development
11.8 CTI BioPharma Corp.
11.8.1 CTI BioPharma Corp. Company Detail
11.8.2 CTI BioPharma Corp. Business Overview
11.8.3 CTI BioPharma Corp. Follicular Lymphoma Treatment Introduction
11.8.4 CTI BioPharma Corp. Revenue in Follicular Lymphoma Treatment Business (2019-2024)
11.8.5 CTI BioPharma Corp. Recent Development
11.9 Curis, Inc.
11.9.1 Curis, Inc. Company Detail
11.9.2 Curis, Inc. Business Overview
11.9.3 Curis, Inc. Follicular Lymphoma Treatment Introduction
11.9.4 Curis, Inc. Revenue in Follicular Lymphoma Treatment Business (2019-2024)
11.9.5 Curis, Inc. Recent Development
11.10 Dynavax Technologies Corporation
11.10.1 Dynavax Technologies Corporation Company Detail
11.10.2 Dynavax Technologies Corporation Business Overview
11.10.3 Dynavax Technologies Corporation Follicular Lymphoma Treatment Introduction
11.10.4 Dynavax Technologies Corporation Revenue in Follicular Lymphoma Treatment Business (2019-2024)
11.10.5 Dynavax Technologies Corporation Recent Development
11.11 Eisai
11.11.1 Eisai Company Detail
11.11.2 Eisai Business Overview
11.11.3 Eisai Follicular Lymphoma Treatment Introduction
11.11.4 Eisai Revenue in Follicular Lymphoma Treatment Business (2019-2024)
11.11.5 Eisai Recent Development
11.12 EpiZyme, Inc.
11.12.1 EpiZyme, Inc. Company Detail
11.12.2 EpiZyme, Inc. Business Overview
11.12.3 EpiZyme, Inc. Follicular Lymphoma Treatment Introduction
11.12.4 EpiZyme, Inc. Revenue in Follicular Lymphoma Treatment Business (2019-2024)
11.12.5 EpiZyme, Inc. Recent Development
11.13 F. Hoffmann-La Roche Ltd.
11.13.1 F. Hoffmann-La Roche Ltd. Company Detail
11.13.2 F. Hoffmann-La Roche Ltd. Business Overview
11.13.3 F. Hoffmann-La Roche Ltd. Follicular Lymphoma Treatment Introduction
11.13.4 F. Hoffmann-La Roche Ltd. Revenue in Follicular Lymphoma Treatment Business (2019-2024)
11.13.5 F. Hoffmann-La Roche Ltd. Recent Development
11.14 Genentech, Inc.
11.14.1 Genentech, Inc. Company Detail
11.14.2 Genentech, Inc. Business Overview
11.14.3 Genentech, Inc. Follicular Lymphoma Treatment Introduction
11.14.4 Genentech, Inc. Revenue in Follicular Lymphoma Treatment Business (2019-2024)
11.14.5 Genentech, Inc. Recent Development
11.15 Gilead Sciences, Inc.
11.15.1 Gilead Sciences, Inc. Company Detail
11.15.2 Gilead Sciences, Inc. Business Overview
11.15.3 Gilead Sciences, Inc. Follicular Lymphoma Treatment Introduction
11.15.4 Gilead Sciences, Inc. Revenue in Follicular Lymphoma Treatment Business (2019-2024)
11.15.5 Gilead Sciences, Inc. Recent Development
11.16 GlaxoSmithKline Plc
11.16.1 GlaxoSmithKline Plc Company Detail
11.16.2 GlaxoSmithKline Plc Business Overview
11.16.3 GlaxoSmithKline Plc Follicular Lymphoma Treatment Introduction
11.16.4 GlaxoSmithKline Plc Revenue in Follicular Lymphoma Treatment Business (2019-2024)
11.16.5 GlaxoSmithKline Plc Recent Development
11.17 Hutchison MediPharma Limited
11.17.1 Hutchison MediPharma Limited Company Detail
11.17.2 Hutchison MediPharma Limited Business Overview
11.17.3 Hutchison MediPharma Limited Follicular Lymphoma Treatment Introduction
11.17.4 Hutchison MediPharma Limited Revenue in Follicular Lymphoma Treatment Business (2019-2024)
11.17.5 Hutchison MediPharma Limited Recent Development
11.18 Immune Design Corp.
11.18.1 Immune Design Corp. Company Detail
11.18.2 Immune Design Corp. Business Overview
11.18.3 Immune Design Corp. Follicular Lymphoma Treatment Introduction
11.18.4 Immune Design Corp. Revenue in Follicular Lymphoma Treatment Business (2019-2024)
11.18.5 Immune Design Corp. Recent Development
11.19 ImmunoGen, Inc.
11.19.1 ImmunoGen, Inc. Company Detail
11.19.2 ImmunoGen, Inc. Business Overview
11.19.3 ImmunoGen, Inc. Follicular Lymphoma Treatment Introduction
11.19.4 ImmunoGen, Inc. Revenue in Follicular Lymphoma Treatment Business (2019-2024)
11.19.5 ImmunoGen, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details